UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000028737
Receipt No. R000032887
Official scientific title of the study Study on the preventive effect of Chinese herbal medicine for deep venous thromboembolism
Date of disclosure of the study information 2017/08/18
Last modified on 2017/08/18 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study on the preventive effect of Chinese herbal medicine for deep venous thromboembolism
Title of the study (Brief title) Prevention of VTE by Chinese herbal medicine
Region
Japan

Condition
Condition Deep venous thromboembolism
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to prove that Chinese herbal medicine is effective for prevention of VTE development after orthopedic surgery
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Presence or absence of deep venous thrombosis at one week after surgery
Key secondary outcomes D-dimer value
Circumference diameter of the thigh and lower leg

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 Chinese herbal medicine(keisibukuryougan)
Interventions/Control_2 Low molecular weight heparin
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
50 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Patient who undergo total knee arthroplasty

Patient who undergo lumbal surgery

Patient who undergo the suegery for proximal femoral fracture
Key exclusion criteria Patients taking anticoagulants
Target sample size 50

Research contact person
Name of lead principal investigator Michiro Yanagisawa
Organization Hirosaki University Hospital
Division name Orthopedic surgery
Address 53 Hon-cho Hirosaki city, Aomori
TEL 0172-39-5083
Email yanagi96@hirosaki-u.ac.jp

Public contact
Name of contact person Michiro Yanagisawa
Organization Hirosaki University Hospital
Division name Orthopedic surgery
Address 53 Hon-cho Hirosaki city, Aomori
TEL 0172-39-5083
Homepage URL
Email yanagi96@hirosaki-u.ac.jp

Sponsor
Institute Hirosaki University Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 08 Month 18 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 08 Month 18 Day
Anticipated trial start date
2017 Year 09 Month 13 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 08 Month 18 Day
Last modified on
2017 Year 08 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032887